Biomet Acquires Massachusetts’ Cytosol Laboratories

Biomet, a Warsaw, Ind.-based musculoskeletal medical products manufacturer, acquired the assets of Cytosol Laboratories, a Braintree, Mass.-based small volume anticoagulants producer, according to a Biomet news release.

Advertisement
Laura Dyrda

Cytosol currently has three proprietary products with new drug application approvals: TriCitrasol, noClot-50 and Rejuvesol.

Read the Biomet news release.

Read other coverage on Biomet.

-Biomet’s Indiana Facility to Expand

-Biomet Sports Medicine Mobile Learning Center to Provide Product Demonstration and Education

-Biomet Announces 4Q FY 2010 Financial Results

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Find the revenue hiding in your dental practice

Recommended Whitepaper

Advertisement

Next Up in Spinal Tech

  • 2 spine medtech lawsuit updates

    Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

    By: Carly Behm

  • Top-paid spine medtech CFOs

    The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

    By: Carly Behm
Advertisement

Comments are closed.